-
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.
Mar 4, 2026
-
Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, will showcase its latest scientific studies and product innovations at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting on March 10-14 in Baltimore, MD. The company will highlight its innovative portfolio at booth #1017 and share a series of presentations and poster sessions throughout the meeting.
Mar 3, 2026
-
Following Proscia’s Global Best in KLAS win in Europe, Concentriq is now the highest-rated digital pathology platform across multiple regions
Mar 1, 2026
-
• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB
• Follows close of initial funding round with investment from Stephen Quake and Jay Flatley
Mar 1, 2026
-
• Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community
• Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively
Feb 24, 2026
-
PrecisionLife and Ovation today announced the results of the first phase of their collaboration to develop drug-response biomarkers to quantitively predict the efficacy, safety and tolerability of glucagon-like peptide-1 receptor agonist (GLP-1) therapies, and the extension of their partnership.
Feb 24, 2026
-
Feb 23, 2026
-
Inceptua Group announces the appointment of Kurt J. Hilzinger as Chairman of the Board.
Feb 23, 2026
-
ClearNote Health announced an enhanced version of its Avantect Pancreatic Cancer Test that delivers a higher overall cancer detection sensitivity of 82.6% and specificity of 97.5%.
Feb 22, 2026
-
Feb 11, 2026
-
Feb 8, 2026
-
New module streamlines standardized CRF (case report form) design and EDC build to help clinical teams start studies faster.
Feb 5, 2026
-
Valley Diagnostics Ltd., a Welsh diagnostics company commercialising next-generation point-of-care lateral flow tests (LFTs), has signed several licencing agreements with its research partner and collaborator Aberystwyth University to bring to market innovative diagnostic tests that will revolutionise disease detection.
Feb 5, 2026
-
Feb 4, 2026
-
Feb 4, 2026
-
The addition of BrightHeart's B-Right AI Platform to the Voluson Solution store is poised to improve early detection of congenital defects, reduce diagnostic uncertainty, and ultimately support better outcomes for clinicians, expectant parents and their babies.
Feb 4, 2026
-
Feb 2, 2026
-
BetterWay blood testing by Babson Diagnostics will launch a GLP-1 test panel at more than 25 retail locations in Austin and Temple, including Sam’s Club and Peoples Rx pharmacies.
Feb 2, 2026
-
• Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America
• Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development
Jan 26, 2026
-
Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices.
Jan 25, 2026